PET reveals inflammatory cycle in the brain

June 8, 2015

Neuroinflammation caused by a reactive immune system could be tripping off the neurodegeneration seen in certain dementias, multiple sclerosis, and other deadly diseases of the nervous system. A novel molecular imaging technique could be the key to understanding how best to treat these and other devastating diseases, according to a recent study presented at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

At the heart of this maladaptive immune response are microglia, in the central nervous system that can be activated to trigger neuroinflammation. For this study, researchers used (PET) to measure activation of microglia by employing a molecule from E. coli bacteria called lipopolysaccharide (LPS), or endotoxin. LPS stimulates the and is accompanied by a radiotracer called carbon-11 PBR28 (C-11 PBR28). This form of allows the minimally invasive visualization of neuroinflammation. C-11 PBR28, is injected and binds to translocator proteins expressed on activated microglia. A PET scanner can then detect the radioactive particles emitted from inside the brain, representing areas of increased microglial activation before and after immune stimulation with LPS.

"The imaging technique could shed light on the that underpins a broad range of neuroinflammatory diseases, such as Alzheimer's disease, depression, and addiction," said Christine Sandiego, PhD, lead author of the study and a researcher from the department of psychiatry at the Yale School of Medicine in New Haven, Conn. "This is the first human study that accurately measures this immune response in the brain. The discoveries made with this technique could contribute to promising new drug treatments."

The PET radiotracer C-11 PBR28 was administered to eight healthy men around the age of 25, give or take six years, followed by two separate PET scans on the same day for each subject before and after injection with LPS. Adverse symptoms were self-reported and blood samples were taken to assess levels of peripheral inflammation. Results of the study showed that administering LPS led to a substantial spike in the systemic inflammatory response and levels of reported sickness, and activated microglia in the central nervous system.

With further research, eventual drug therapies could potentially cut the activation of neurodegenerative microglia and encourage neuroprotective processes in the brain.

Explore further: The Japanese traditional therapy, honokiol, blocks key protein in inflammatory brain damage

More information: Scientific Paper 468: "Systemic endotoxin induces a robust increase in microglial activation measured with [11C]PBR28 and PET in humans"

Related Stories

Researchers discover neuroprotective role of immune cell

July 22, 2014

A type of immune cell widely believed to exacerbate chronic adult brain diseases, such as Alzheimer's disease and multiple sclerosis (MS), can actually protect the brain from traumatic brain injury (TBI) and may slow the ...

Recommended for you

New insights into the information processing of motor neurons

February 21, 2017

In a study published in Cell Reports in February 2017, Matt Rowan, Ph.D., a Post-doctoral researcher in the lab of Dr. Jason Christie, sought to understand the molecular mechanisms behind a type of short-term neuronal plasticity ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.